Opposing Effects of Particle Pollution, Ozone, and Ambient Temperature on Arterial Blood Pressure by Luttmann-Gibson, Heike et al.
 
Opposing Effects of Particle Pollution, Ozone, and Ambient
Temperature on Arterial Blood Pressure
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Hoffmann, Barbara, Heike Luttmann-Gibson, Allison Cohen,
Antonella Zanobetti, Celine de Souza, Christopher Foley, Helen
H. Suh, et al. 2012. Opposing effects of particle pollution, ozone,
and ambient temperature on arterial blood pressure.
Environmental Health Perspectives 120(2): 241-246.
Published Version doi://10.1289/ehp.1103647
Accessed February 19, 2015 9:31:17 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10282867
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAEnvironmental Health Perspectives  •  v o l u m e  120 | n u m b e r 2 | February 2012  241
Research
Persons with diabetes were at higher risk of 
dying during recent European heat waves 
(Schifano et al. 2009) and had increased rates 
of cardiovascular death when exposed to ele-
vated levels of particulate matter (PM) pol-
lution (Goldberg et al. 2001; Zanobetti et al. 
2009). The potential biological mechanisms 
that mediate this hypothesized increased sus-
ceptibility to environmental effects include 
heat-associated orthostatic hypotension 
(Crandall and González-Alonso 2010) and 
air-pollution–induced autonomic imbalance, 
oxidative stress, and systemic inflammation 
(Brook et al. 2010), which promote endothe-
lial dysfunction (Madrigano et al. 2010), 
impaired vascular reactivity, and hypertension 
(Brook et al. 2009). Although it is possible 
that heat-associated hypotension or pollution-
associated hypertension and endothelial dys-
function contribute to the risk of death, the 
combined effects of climate and pollution on 
blood pressure (BP) regulation are not well 
understood.
Persons with diabetes may be at greater 
risk for environmental perturbations of 
mechanisms that regulate BP. Diabetes 
itself increases the risk of hypertension and 
orthostatic hypotension because of chronic 
autonomic dysregulation, endothelial dys-
function, atherosclerosis, and dysregulation 
of fluid balance and the renin-angiotensin sys-
tem (Pop-Busui 2010; Ribeiro-Oliveira et al. 
2008). Common medications, such as beta 
blockers, may further block appropriate com-
pensatory autoregulatory vascular responses 
(Bell 2009). We have shown that elevated PM 
pollution exposure adds to autonomic dysreg-
ulation, endothelial dysfunction (O’Neill et al. 
2005), and inflammation (Dubowsky et al. 
2006), particularly in persons with diabetes. 
Moreover, poor diabetes control increases the 
risk of autonomic dysfunction (Pop-Busui 
2010), but it is not known whether optimal 
control of glucose or BP ameliorates the effects 
of pollution or high temperature.
In this study, we investigated the combined 
short-term effects of PM air pollution, ozone, 
and ambient temperature on systolic BP (SBP), 
diastolic BP (DBP), and central mean arterial 
BP in a panel of 70 subjects with type 2 diabetes 
mellitus (T2DM). We also evaluated whether 
BP or glucose control in persons with diabetes 
modulated the effects of pollution or climate.
Methods
Study population and design. This analysis 
is based on a panel study of subjects with 
T2DM and was specifically designed to 
examine vascular and autonomic function as 
well as inflammatory changes associated with 
acute changes in air pollution and its con-
stituents. From September 2006 through July 
2010, subjects with T2DM were recruited for 
screening for a prospective repeated measures 
study if they were 40–85 years of age and lived 
within 25 km of the central air monitoring site 
in Boston. Exclusion criteria focused on 
Exposures that could obscure ambient pollu- •	
tion measurement (e.g., secondhand tobacco 
smoke at home, living beyond 25 km of the 
central monitoring station)
Conditions with electro  physiological or vas- •	
cular effects (e.g., current atrial   fibrillation/
flutter; history of clinically significant 
ventricular arrhythmias, pacemaker, or 
implanted defibrillator; acute myocardial 
infarction or stent placement within the pre-
ceding 6 months)
Clinical/biomarker parameters requir- •	
ing immediate attention [e.g., uncon-
trolled hypertension (> 180 mmHg SBP, 
> 105 mmHg DBP)]
Other advanced diseases (e.g., solid organ  •	
transplant, active autoimmune disease, 
dementia, diabetes type 1, renal failure, 
  seizure disorder or stroke, sleep apnea). 
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Ba c k g r o u n d: Diabetes increases the risk of hypertension and orthostatic hypotension and raises 
the risk of cardiovascular death during heat waves and high pollution episodes.
oB j e c t i v e: We examined whether short-term exposures to air pollution (fine particles, ozone) and heat 
resulted in perturbation of arterial blood pressure (BP) in persons with type 2 diabetes mellitus (T2DM).
Me t h o d s : We conducted a panel study in 70 subjects with T2DM, measuring BP by automated 
oscillometric sphygmomanometer and pulse wave analysis every 2 weeks on up to five occasions 
(355 repeated measures). Hourly central site measurements of fine particles, ozone, and   meteorology 
were conducted. We applied linear mixed models with random participant intercepts to investigate 
the association of fine particles, ozone, and ambient temperature with systolic, diastolic, and mean 
arterial BP in a multipollutant model, controlling for season, meteorological variables, and subject 
characteristics.
re s u l t s: An interquartile increase in ambient fine particle mass [particulate matter (PM) with an 
aerodynamic diameter of ≤ 2.5 μm (PM2.5)] and in the traffic component black carbon in the previ-
ous 5 days (3.54 and 0.25 μg/m3, respectively) predicted increases of 1.4 mmHg [95% confidence 
interval (CI): 0.0, 2.9 mmHg] and 2.2 mmHg (95% CI: 0.4, 4.0 mmHg) in systolic BP (SBP) at 
the population geometric mean, respectively. In contrast, an interquartile increase in the 5-day 
mean of ozone (13.3 ppb) was associated with a 5.2 mmHg (95% CI: –8.6, –1.8 mmHg) decrease 
in SBP. Higher temperatures were associated with a marginal decrease in BP.
co n c l u s i o n s: In subjects with T2DM, PM was associated with increased BP, and ozone was 
  associated with decreased BP. These effects may be clinically important in patients with already 
compromised autoregulatory function.
key w o r d s : air pollution, ambient temperature, blood pressure, diabetes mellitus, epidemiol-
ogy, ozone, particles. Environ Health Perspect 120:241–246 (2012).  http://dx.doi.org/10.1289/
ehp.1103647 [Online 21 October 2011]Hoffman et al.
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Five follow-up clinic visits were scheduled 
2 weeks apart on the same weekday in the 
morning. Subjects were asked to fast for the 
12 hr before the clinical measurements. Clinic 
visits included a personal interview on socio-
demographic characteristics, health status, 
medical history, medication, and lifestyle; 
blood and urinary analysis; and clinical exami-
na  tions. The study protocol was approved by 
the institutional review board at the Brigham 
and Women’s Hospital, the Joslin Diabetes 
Clinic, and the Harvard School of Public 
Health. All participants provided written 
informed consent.
Air pollution and meteorology. Ambient 
air pollution monitoring was conducted at a 
central site operated by the Harvard School 
of Public Health. The monitoring station was 
located on a rooftop approximately 500 m 
from the examination site. Particle measure-
ments included PM with aerodynamic diam-
eter ≤ 2.5 μm (PM2.5), sulfate (SO4
2–), black 
carbon (BC), elemental carbon (EC), organic 
carbon (OC), and particle number concentra-
tion (PNC). Continuous PM2.5 [measured 
using a tapered element oscillating microbal-
ance sampler (TEOM) 1400A; Rupprecht 
and Patashnick, Albany, NY, USA] represents 
the overall mass of particles < 2.5 μm in aero-
dynamic diameter. We used a season-specific 
correction factor, based on the data from a 
collocated gravimetric sampler, to compensate 
for semivolatile mass lost using the TEOM 
sampler. SO4
2– particles (measured using a sul-
fate particulate analyzer model 5020; Thermo 
Fisher Scientific, Waltham, MA, USA) are 
formed through secondary reactions of sul-
fur dioxide emitted primarily by coal-burning 
power plants and often transported region-
ally over long distances (e.g., hundreds of kilo-
meters) (Thurston and Spengler 1985). BC 
(measured using a model AE-14 Aethalometer; 
Magee Scientific, Berkeley, CA, USA) is 
used to indicate traffic emissions, especially 
those related to diesel fuel combustion. OC 
(measured using an EC-OC analyzer; Sunset 
Laboratory Inc., Tigard, OR, USA) originates 
mainly from biomass and fossil fuel combus-
tion and from secondary formation of gas-
phase precursors. PNC (measured using a 
condensation particle counter model 3022a; 
TSI Inc., Shoreview, MN, USA) reflects ultra-
fine combustion-related particles (< 100 nm) 
and indexes fresh, locally generated traffic par-
ticles (Morawska and Zhang 2002).
Hourly ambient concentrations of ozone 
were obtained from the Massachusetts 
Department of Environmental Protection 
(Boston, MA) for the greater Boston area. 
We calculated hourly mean ozone concentra-
tions from data reported by all air pollution 
monitoring stations. Hourly mean tempera-
ture, relative humidity, and barometric pres-
sure measurements were collected from the 
National Weather Service Station at Logan 
Airport (East Boston) located approximately 
12 km from the examination site.
We imputed missing hourly data for 
PM2.5 and BC using regression model-
ing, including a long-term time trend, day 
of week, hour of day, temperature, relative 
humidity, barometric pressure, and nitrogen 
dioxide as predictors. All collections, process-
ing of samples, analysis, and reporting were 
conducted according to standard operating 
procedures (Dockery et al. 2005).
BP measurements. All clinical measure-
ments were performed by trained study per-
sonnel in a temperature-controlled room 
(22–24°C). After a 5-min period of rest, bra-
chial artery BP of the dominant arm of seated 
participants was measured three times at 1-min 
intervals, using an automated oscillometric 
sphygmomanometer (OSZ5; WelchAllyn, 
Skaneateles Falls, NY, USA). We used the aver-
age of the second and third measurement. If 
SBP was > 180 mmHg, the measurement was 
repeated after an additional 5 min of rest. If 
SBP remained > 180 mmHg, the study doctor 
was notified and came to examine and speak to 
the patient to determine if the study visit could 
continue. Central mean arterial BP was derived 
from pulse wave analysis, conducted with a 
SphygmoCor Px Pulse Wave Analysis System 
(model SCOR-Px; Atcor Medical Pty Ltd., 
Sydney, Australia). In a seated position, partici-
pants extended their dominant arm onto a flat 
surface, ensuring that the elbow was at heart 
level. Applanation tonometry of the radial 
artery, guided by visual inspection of the pulse 
pressure (PP) wave form and by a built-in qual-
ity score of the homogeneity of the observed 
waveforms, was conducted to record 10 sec 
of sequential peripheral pulse waveforms. The 
peripheral wave forms were transformed into 
corresponding central aortic waveforms via a 
previously validated transfer function (Chen 
et al. 1997). Central mean arterial BP, PP, 
augmentation pressure (AP), and augmenta-
tion index (AI) were derived from the aortic 
pressure wave. The AI is defined as the differ-
ence between the first and second systolic peak 
(i.e., AP), divided by PP, and expressed as a 
percentage: AI (%) = (AP/PP) × 100. Larger 
values indicate a higher pulse wave velocity and 
earlier return of the reflected wave, caused by 
increased arterial stiffness or vascular resistance. 
Because AP and AI are strongly dependent on 
heart rate, values were normalized to a heart 
rate of 75 beats/min (bpm).
Covariates. Current medications were 
coded according to the World Health 
Organization (WHO) Anatomical Therapeutic 
Chemical classification system at each visit 
(WHO Collaborating Centre for Drug 
Statistics Methodology 2011). Body mass 
index (BMI) was calculated at each visit from 
height (measured only at baseline) and weight 
measurements. Presence of coronary heart 
disease was assessed by review of the subjects’ 
medical records. Baseline lipid and HbA1c 
(glycosylated hemoglobin) levels were meas-
ured using standard methods. Blood glucose 
and C-reactive protein levels were measured at 
each visit using standard methods.
Statistical analysis. We used linear mixed 
models that accounted for repeated measures 
within one subject to estimate the effect of 
short-term increases in PM (PM2.5, SO4
2–, BC, 
OC, PNC), ozone, and temperature on changes 
in SBP, DBP, and central mean   arterial BP.
BP values were skewed and, therefore, 
were log-transformed to stabilize the variance. 
Mixed models included a random intercept 
for subject in the analysis, a first-order auto-
regressive term, and subject charac  teristics 
(i.e., age, sex, BMI, HbA1c), season, and 
ambient temperature. Exposure metrics 
included short-term exposure periods 
(mean values during the 1–5 days before the 
BP measurement). Estimates are given as 
the percent change in BP per interquartile 
range (IQR) change in exposure with 95% 
confidence intervals (CIs), or as the absolute 
change in BP (millimeters of mercury) 
calculated at the population geometric mean.
In the base models, we included one 
environ  mental exposure (PM pollution, 
ozone, or temperature) and controlled for sea-
son, age, sex, and BMI. Other personal char-
acteristics (e.g., years of diabetes, HbA1c at 
baseline, and blood glucose level on the morn-
ing of the visit) were added if they improved 
model fit. Continuous variables were included 
as polynomials if there were signs of depar-
ture from linearity. The time course for the 
relation of exposure to BP was explored sepa-
rately for each environmental exposure con-
sidered. We then estimated the effects of PM, 
ozone, and temperature in models including 
all of these environmental exposures, using 
the mean value for the time window of expo-
sure that was most strongly (i.e., the largest 
point estimate) associated with BP for each 
exposure. In extended models, HbA1c, anti-
hypertensive medication and blood glucose 
on the day of the clinic visit were included.
In sensitivity analyses, we investigated the 
association between PM air pollution and 
BP outcomes only in participants who lived 
within 15 km of the central measuring station. 
We also investigated the association by includ-
ing fixed effects for subjects in the analysis to 
remove between-subject variation.
Using interaction terms, we evaluated 
baseline BP level, intake of antihypertensive 
medication, AI, BMI, C-reactive protein, 
HbA1c, duration of diabetes, and season as 
potential modifiers of the relation of pollution 
or temperature to BP. To derive interaction 
terms of exposure variables with continuous 
variables, we dichotomized the potential effect Air pollution, temperature, and blood pressure
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modifier at the median. Statistical analyses 
were performed using SAS (version 9.2; SAS 
Institute Inc., Cary, NC, USA).
Results
During the study period from September 
2006 through July 2010, 70 participants were 
enrolled in the repeated measures study, with 
a mean of 4.8 repeated observations each 
(Table 1), resulting in 322 observations with 
complete information on outcome and cova-
riates. Most participants had a long-standing 
history of diabetes (mean, 9.9 years; median, 
8.0 years). Obesity, hypertension, and anti-
hypertensive medication were highly preva-
lent in this population.
Ambient PM2.5 concentrations in Boston 
were below the currently set U.S. daily standard 
during the study period (Table 2). Fine particle 
metrics (PM2.5, SO4
2–, BC, and OC) were 
highly correlated with each other but not with 
PNC, ozone, and temperature. PNC and mean 
temperature had a high negative correlation 
(Table 2); ozone and temperature were mod-
erately positively correlated in the non-winter 
seasons [Spearman’s rho (rS) = 0.44].
BP tended to increase with elevations in 
levels of fine particle mass averaged over the 1–5 
days before examination (Figure 1, Table 3). 
Elevations in PM2.5 and BC were most 
consistently and precisely linked to elevated BPs 
in the full model. For example, an IQR increase 
in ambient PM2.5 (3.54 μg/m3) and BC (0.25   
μg/m3) in the previous 5 days predicted an 
increase in SBP of 1.1% (95% CI: 0.0%, 2.2%) 
and 1.7% (95% CI: 0.3%, 3.1%), respectively 
(Table 3). This represents absolute increases in 
SBP of 1.4 mmHg (95% CI, 0.0, 2.9 mmHg) 
and 2.2 mmHg (95% CI, 0.4, 4.0 mmHg), 
respectively. Effects on central mean arterial 
BP derived from the central BP curve showed a 
similar pattern, but were lower overall.
In contrast to the rise in BP with increas-
ing PM pollution, increases of mean ozone 
levels over the 3–5 days before examination 
were associated with considerable decreases in 
BP (Table 3, Figure 2). For an IQR increase 
in the 5-day mean of ozone, SBP, DBP, and 
central mean arterial BP decreased by 4.0%, 
2.0%, and 2.8%, respectively (Table 3), lead-
ing to an absolute decrease of 5.2 mmHg (95% 
CI: –8.6, –1.8 mmHg), 1.5 mmHg (95% CI: 
–3.1, 0.2 mmHg), and 2.6 mmHg (95% CI: 
–4.9, 0.3 mmHg), respectively. Higher ambi-
ent temperatures during the 1–5 days before 
the examination were also associated with lower 
BP. For example, an increase in 5-day mean 
temperature by 11.5°C (IQR) was associated 
with relative and absolute decreases in SBP of 
2.5% (95% CI: –5.1%, 0.2%) and 3.2 mmHg 
(95% CI: –6.6, 0.3 mmHg), respectively, in 
the model without ozone. The BP-lowering 
effect of temperature was attenuated when 
simultaneously adjusting for ozone (–1.8%; 
95% CI: –4.5%, 1.0%; Table 3, Figure 2).
In subjects with higher baseline BP, BP 
increased more after PM exposure (Table 4). 
On the other hand, decreases in BP after high 
ozone and high temperature exposure were 
considerably stronger in those with lower base-
line BP. Furthermore, subjects with higher 
HbA1c at baseline tended to react more 
strongly to increases in PM exposure. Other 
personal characteristics and the season during 
which the examination took place did not con-
sistently modify associations (Table 4).
Effect estimates were slightly reduced 
but not qualitatively changed after excluding 
outliers (data not shown). Different model 
specifications, such as the inclusion of addi-
tional personal characteristics, did not have an 
impact on the results (data not shown). When 
we included fixed effects for participants, 
effect estimates were unchanged compared 
with the main analysis with the exception of 
estimates for 5-day average BC and PM2.5, 
which were increased in magnitude with 
somewhat improved precision. For example, 
for an interquartile increase in 5-day BC, the 
linear mixed model predicted a 1.7% (95% 
CI: 0.3%, 3.1%) increase in SBP, whereas a 
fixed effect model predicted a 1.9% (95% CI: 
0.5%, 3.4%) increase in SBP. Reducing the 
study area to a smaller buffer of 15 km around 
the central monitoring site led to a substantial 
(20%) decrease in sample size (leaving 257 of 
322 observations). The magnitude of the effects 
Table 1. Baseline characteristics of 70 participants with T2DM in Boston, Massachusetts (USA): 
September 2006 through July 2010.
Characteristic Mean (range) or n (%)
No. of follow-up visits/subject 4.8 (1–5)
Age (years) 64.4 (45–86)
SBP (mmHg) 132 (100–179)
DBP (mmHg) 75 (58–98)
Central mean arterial pressure (mmHg) 95 (70–128)
AP at 75 bpm (mmHg) 11.6 (3.0–32.0)
AI at 75 bpm (%) 25.6 (10.0–44.3)
BMI (kg/m2) 31.3 (20.5–57.0)
HbA1c (%) 7.0 (5.5–10.0)
Years of diabetesa 9.9 (1–38)
Women 37 (53)
Race
Caucasian 58 (83)
Black 7 (10)
Other 5 (7)
Self-reported diagnoses
Hypertension 53 (76)
Coronary artery disease 7 (10)
Antihypertensive medication 53 (76)
Beta blockers 25 (36)
Calcium channel blockers 15 (21)
Angiotensin-converting enzyme inhibitors 30 (43)
Angiotensin II receptor blockers 19 (27)
Lipid-lowering medication 61 (87)
Platelet aggregation inhibitors 52 (74)
aBased on 67 observations because of missing data.
Table 2. Summary statistics and Spearman correlation coefficients of daily mean air pollutant concentrations and meteorological variables in Boston, 
Massachusetts (USA): September 2006 through July 2010.
Summary statistics rS
Exposure
No. of daily environmental 
measurements Mean First quartile  Median Third quartile SO4
2– BC OC PNC Ozone Temp
PM2.5 (μg/m3) 1,341 8.6 5.3 7.3 10.5 0.75 0.66 0.61 –0.13 0.09 0.27
SO4
2– (μg/m3) 1,079 2.2 1.0 1.6 2.6 1 0.52 0.51 –0.22 0.04 0.22
BC (μg/m3) 1,402 0.60 0.37 0.53 0.76 1 0.60 0.01 –0.21 0.28
OC (μg/m3) 935 3.5 2.6 3.3 4.3 1 –0.01 0.12 0.08
PNC (1,000/cm3) 1,390 14.5 9.6 14.3 18.5 1 –0.39 –0.77
Ozone (ppb) 1,430 25 18 24 32 1 0.37
Mean temperature (°C) 1,461 11.2 3.8 11.8 19.0 1Hoffman et al.
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were generally reduced, but precision decreased 
as well, making interpretation difficult (data 
not shown).
Discussion
To the best of our knowledge, this is the first 
study to report evidence of independent and 
diametrically opposed effects of ambient PM 
pollution, gaseous pollution (ozone), and cli-
mate (temperature) on persons with diabetes. 
Although particle pollution, specifically traffic-
related particles, was associated with increased 
BP, ozone and (less consistently) high tem-
peratures were associated with reduced BP. 
Estimated effects of particle pollution on BP 
were stronger in subjects with suboptimal BP 
and diabetes control.
Clinical implications. Persons with dia-
betes mellitus appear to be particularly vul-
nerable to environmental stressors such as 
air pollution and heat, as suggested by an 
increased risk of cardiovascular hospital admis-
sions and all-cause mortality (Goldberg et al. 
2001; O’Donnell et al. 2011; Schifano et al. 
2009; Zanobetti et al. 2009). Although the 
potential biological mechanisms that medi-
ate this hypothesized increased susceptibility 
remain unclear, it is well known that persons 
with diabetes suffer from impaired BP regula-
tion with increased risk of both hypertension 
and orthostatic hypotension. Because of auto-
nomic dysregulation, endothelial dysfunction, 
fluid shifts, and medication effects, they may 
be unable to accommodate in a timely or effec-
tive manner to environment-related increases 
or decreases in BP.
The clinical implications of environment-
induced BP changes could be substantial. An 
increase in left ventricular afterload caused 
by PM-induced elevated BP could lead to an 
increase in myocardial oxygen demand that 
might not be adequately compensated in per-
sons with compromised vascular function, 
which is common with diabetes. Thus, PM 
pollution-induced increases in left ventricular 
afterload could partially explain the increased 
vulnerability of persons with diabetes to 
cardio  vascular death, myocardial infarction, 
and stroke with short-term increases in air 
pollution (Goldberg et al. 2001; O’Donnell 
et al. 2011; Zanobetti et al. 2009). Repeated 
environ  mentally induced elevations in BP 
would also lead to repeated increases in arte-
rial wall stress, potentially causing reactive 
hypertrophy of arteriolar smooth muscle cells, 
a process that contributes to the fixation of 
chronically elevated pressures. Epidemiological 
evidence for a chronic increase in arterial BP 
is emerging from population-based studies 
(Chuang et al. 2011; Fuks et al. 2011). We 
saw smaller estimated effects on central mean 
arterial pressure derived from the aortic PP 
curve. Because central mean arterial pressure 
is not only a function of SBP but also largely 
influenced by the diastolic decay of arterial BP, 
this outcome measure is not sensitive enough 
to reflect small elevations in peak SBP.
Although long-term BP reduction is gener-
ally beneficial to patients with diabetes, acute 
decreases might be harmful if they lead to 
symptomatic hypotension or impaired cardiac 
or cerebral perfusion. Our data suggest that 
ozone and high temperature lowered BP only 
Figure 1. Estimated relative change (and 95% CI) of SBP related to short-term increases of PM, per IQR of 
the exposure metric. Estimates adjusted for ozone (5-day mean), temperature (4-day mean), season, age, 
sex, BMI, and years of diabetes.
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Figure 2. Estimated relative change (and 95% CI) 
of SBP related to short-term increases of ozone 
and temperature, per IQR of the exposure metric. 
Estimates adjusted for each other and for PM2.5 
(5-day mean), season, age, sex, BMI, and years of 
diabetes.
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Table 3. Estimated relative change [percent change (95% CI)] of arterial BP related to increases in the 
2- and 5-day mean of PM, ozone, and temperature.
Exposure
IQR of exposure 
metric SBP DBP Central mean BP 
PM2.5 (μg/m3)
2-day mean 4.2 0.8 (0.0, 1.7) 0.8 (0.1, 1.5) 0.4 (–0.4, 1.1)
5-day mean 3.5 1.1 (0.0, 2.2) 1.0 (0.1, 1.9) 0.6 (–0.4, 1.7)
SO4
2– (μg/m3)
2-day mean 1.5 0.3 (–1.0, 1.5) 0.6 (–0.4, 1.7) –0.2 (–1.4, 0.9)
5-day mean 1.2 0.5 (–0.6, 1.6) 0.4 (–0.5, 1.3) –0.1 (–1.1, 1.0)
BC (μg/m3)
2-day mean 0.34 1.1 (–0.2, 2.3) 0.7 (–0.3, 1.8) 0.7 (–0.5, 1.8)
5-day mean 0.25 1.7 (0.3, 3.1) 1.5 (0.3, 2.6) 0.9 (–0.4, 2.2)
OC (μg/m3)
2-day mean 1.5 1.4 (–0.1, 3.0) 1.2 (–0.1, 2.5) 0.7 (–0.8, 2.3)
5-day mean 1.3 1.1 (–0.6, 2.8) 1.4 (0.0, 2.8) 0.3 (–1.3, 2.0)
PNC (1,000/cm3)
2-day mean 7.3 1.6 (–0.6, 3.9) 0.2 (–1.7, 2.1) 0.8 (–1.3, 2.9)
5-day mean 6.6 1.1 (–1.6, 4.0) 0.1 (–2.2, 2.5) 0.2 (–2.4, 2.9)
Ozone (ppb)
2-day mean 13.7 –0.6 (–2.5, 1.4) 0.1 (–1.5, 1.7) –0.3 (–2.1, 1.5)
5-day mean 13.3 –4.0 (–6.6, –1.4) –2.0 (–4.2, 0.2) –2.8 (–5.2, –0.3)
Temperature (°C)
2-day mean 12.3 –1.0 (–3.4, 1.6) –0.5 (–2.5, 1.6) –1.1 (–3.4, 1.3)
5-day mean 11.5 –1.8 (–4.5, 1.0) –1.7 (–3.9, 0.5) –2.1 (–4.6, 0.4)
All estimates are adjusted for season, age, sex, BMI, and years of diabetes. PM estimates are also adjusted for ozone 
(5-day mean) and temperature (4-day mean). Ozone and temperature effects are also adjusted for each other and for 
PM2.5 (5-day mean).Air pollution, temperature, and blood pressure
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when BP was already either optimally con-
trolled (American Diabetes Association 2010) 
or relatively low. Further lowering of BP in 
these circumstances could lead to adverse 
events. Patients with diabetes tend to have 
depressed heart rate variability and autonomic 
dysfunction and frequently are already taking 
beta blockers (Bell 2009). Particularly if their 
glucose levels are not well controlled, they 
also may become fluid depleted and hypo-
volemic during periods of concurrent high 
temperature and high ozone concentrations. 
Because their BP compensatory mechanisms 
are deficient, they may be less able to respond 
with appropriate vasoconstriction (Pop-Busui 
2010; Ribeiro-Oliveira et al. 2008). Even sub-
tle reductions in central mean arterial pressure 
could contribute to lower diastolic filling of 
the coronary arteries, with deleterious effects 
on myocardial oxygen supply, or to reduced 
cerebrovascular perfusion. Because ozone and 
PM air pollution are not correlated, contrary 
effects on BP are not expected to cancel each 
other out but may act independently, exacer-
bating the already compromised BP regulation 
of diabetic patients.
Biological mechanisms. We have pre-
viously documented elevations in BP with 
increased PM pollution in patients under-
going cardiac rehabilitation, and now a grow-
ing body of literature reflects the replication 
of our findings in other populations (Brook 
et al. 2011; Chuang et al. 2010; Delfino 
et al. 2010; Dvonch et al. 2009; Madsen and 
Nafstad 2006) and demonstrates mechanisms 
for BP effects in animal models (Bartoli et al. 
2009). In the present study, a PM-induced 
increase in BP occurred within 24 hr after 
elevated exposures and was sustained for up 
to 5 days. Activation of pulmonary reflexes, 
imbalance in autonomic function, activa-
tion of the renin-angiotensin system, and 
an increase in endothelin, resulting in an 
increased vasomotor tone, are possible bio-
logical mechanisms (Brook 2008; Liu et al. 
2009; Luttmann-Gibson et al. 2010). An 
effect sustained for up to 5 days is more likely 
to be mediated by slower-acting mechanisms 
such as the induction of systemic inflamma-
tion (Dubowsky et al. 2006). Because poor 
glucose control is linked to increased systemic 
inflammation, adverse effects of pollution-
induced inflammation and increases in BP 
could be reduced by improved glucose con-
trol. This may explain why study participants 
with HbA1c < 6.7% had less of an increase in 
BP in response to increased PM pollution.
Ozone is an oxidant with immediate effects 
on pulmonary reflexes (Lee and Pisarri 2001), 
but its effect on BP is less well documented. 
Ozone may also be a marker for secondary 
pollution exposure related to regional pollu-
tion, including transported traffic emissions. In 
single-pollutant models, Chuang et al. (2010) 
showed a small increase in DBP with increas-
ing ozone in a Taiwanese cross-sectional study, 
and Zanobetti et al. (2004) found an increase 
in DBP in a panel of cardiac rehabilitation 
patients. However, a lack of adjustment for 
other air pollutants might have confounded the 
ozone estimates in these studies. Other studies 
did not show an independent effect of ozone, 
but these studies either were limited to acute 
effects within hours of exposure (Brook et al. 
2009) or might have suffered from substantial 
exposure misclassification because of a presum-
ably high prevalence of air-conditioning in a 
study population of elderly subjects with coro-
nary heart disease living in retirement homes in 
California (Delfino et al. 2010). In a controlled 
chamber study of normal young adults, we 
found that combined ozone and concentrated 
ambient PM exposure increased DBP, but 
ozone alone did not (Fakhri et al. 2009).
Ozone is a known local vasodilator that 
has been used in the form of reinfused ozon-
ated plasma in therapy for local peripheral 
ischemia (Valacchi and Bocci 2000). However, 
inhalation of ambient ozone is not comparable 
to these therapeutic measures, and we can only 
speculate regarding potential biological mech-
anisms explaining our findings. Ozone selec-
tively activates a subset of bronchopulmonary 
C-fibers in mice, which can lead to brady-
cardia, a fall in cardiac output, and bronchial 
vasodilation that increases airway blood flow 
despite systemic hypotension (Lee and Pisarri 
2001; Taylor-Clark and Undem 2010). Thus, 
it is physiologically plausible that ozone, inde-
pendent of the peripheral vasodilation caused 
by high temperatures (Halonen et al. 2010), 
may cause systemic hypotension in humans. 
It is, however, unclear how this relates to 
the associations we observed after prolonged 
  exposure of several days.
Limitations and strengths. Limitations of 
this study include possible exposure misclassi-
fication due to the use of central monitoring 
data. Several mechanisms of exposure misclassi-
fication have to be considered. First, the central 
site measurement does not reflect the absolute 
level of personal exposure, which probably dif-
fers from the central measurements because of 
characteristics of the individuals’ homes (e.g., 
proximity to traffic) and differences in personal 
behavior (e.g., heating and ventilation hab-
its, leisure time and occupational activities). 
Therefore, we used a random participant inter-
cept in the analysis to account for differences of 
the absolute level of exposure of each subject. 
Table 4. Effect modification of PM, ozone, and temperature effects on SBP.
PM2.5 BC Ozone Temperature
Characteristic
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Percent change 
(95% CI) p-Value
Baseline SBP
< 132 mmHg –0.9 (–2.2, 0.3) — –0.6 (–2.1, 0.9) — –7.0 (–9.6, –4.3) — –5.2 (–8.0, –2.4) —
≥ 132 mmHg 2.9 (1.6, 4.2) < 0.001 4.5 (2.8, 6.2) < 0.001 –0.9 (–3.7, 1.9) < 0.001 3.0 (0.0, 6.1) < 0.001
Antihypertensive medication
No 1.1 (–0.4, 2.6) — 2.3 (0.3, 4.3) — –2.9 (–6.1, 0.3) — –1.7 (–5.3, 2.0) —
Yes 1.1 (–0.1, 2.3) 0.991 1.5 (0.1, 3.0) 0.421 –4.4 (–7.0, –1.7) 0.223 –1.8 (–4.6, 1.0) 0.937
AI
< 26.2% 1.1 (–0.2, 2.4) — 1.6 (0.0, 3.1) — –4.4 (–7.2, –1.6) — –2.0 (–4.9, 1.0) —
≥ 26.2% 1.1 (–0.2, 2.4) 0.988 1.9 (0.2, 3.7) 0.725 –3.4 (–6.3, –0.5) 0.357 –1.5 (–4.6, 1.7) 0.727
BMI
< 30.6 kg/m2 0.9 (–0.5, 2.3) — 2.0 (0.3, 3.7) — –3.6 (–6.5, –0.6) — –1.8 (–4.9, 1.4) —
≥ 30.6 kg/m2 1.2 (–0.1, 2.6) 0.686 1.4 (–0.4, 3.1) 0.536 –4.4 (–7.3, –1.5) 0.515 –1.8 (–4.8, 1.4) 0.988
HbA1c
< 6.7% 0.6 (–0.6, 1.8) — 0.9 (–0.7, 2.6) — –4.3 (–7.1, –1.4) — –2.9 (–5.8, 0.1) —
≥ 6.7% 2.0 (0.5, 3.5) 0.058 2.4 (0.8, 4.0) 0.082 –3.7 (–6.5, –0.9) 0.597 –0.4 (–3.5, 2.8) 0.089
Diabetes mellitus
< 8 years 1.1 (–0.1, 2.4) — 1.8 (0.3, 3.4) — –3.9 (–6.6, –1.1) — –1.7 (–4.5, 1.2) —
≥ 8 years 1.0 (–0.3, 2.4) 0.839 1.5 (–0.1, 3.2) 0.724 –4.3 (–7.2, –1.3) 0.733 –2.0 (–5.2, 1.3) 0.851
Estimates are given per IQR of the exposure metric. The p-value refers to the interaction term. Estimates are displayed for the 5-day mean concentration of PM2.5, BC, and ozone and 
for the 4-day mean of ambient temperature. All estimates are adjusted for season, age, sex, BMI, and years of diabetes. PM estimates are also adjusted for ozone (5-day mean) and 
temperature (4-day mean). Ozone and temperature effects are also adjusted for each other and for PM2.5 (5-day mean).Hoffman et al.
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Second, the study relied upon temporal varia-
tion in exposure before each of the five clinic 
visits, which were scheduled 2 weeks apart. 
This temporal variation in exposure from week 
to week is mainly influenced by meteorology 
on a regional scale. We therefore excluded sub-
jects residing outside a 25-km circle around 
the monitoring site to ensure homogeneous 
meteoro  logi  cal conditions within our study 
area. Finally, differential exposure misclassifi-
cation may have resulted if participants spent 
more time indoors on very hot days when 
ambient ozone concentrations are high, thus 
reducing their personal exposure relative to 
ambient levels. Interestingly, the estimated 
effect of ozone was not modified by season, 
as would be expected with increasing exposure 
misclassification on hot summer days.
Other limitations include the compara-
tively small sample size. The high negative cor-
relation between temperature and PNC limited 
our power to examine the concurrent effect of 
both of these environmental exposures.
Strengths of this study include its repeated 
measures study design, which enables control 
of potentially confounding personal charac-
teris  tics in a real-life setting. In contrast to 
controlled exposure studies, this study esti-
mates the actual effect of ambient air pol-
lutants in a subgroup of the population. We 
minimized non-air-pollution sources of vari-
ance by strict inclusion and exclusion criteria. 
Further analy  ses, making use of the compre-
hensive assessment of exposures and inter-
mediary factors that was conducted in this 
study, will allow investigations of the mecha-
nisms and biological pathways of PM effects.
Conclusions
We report evidence that PM air pollution 
raised arterial BP, whereas ozone decreased 
BP, including central mean arterial pressure, 
in persons with T2DM. These estimated 
effects appeared to be independent of each 
other and were of a magnitude that could 
result in clinically significant hemodynamic 
consequences for this vulnerable population. 
Optimal BP and glucose control may reduce 
adverse effects of traffic pollution on increases 
in BP, but diabetes patients with baseline BP 
that is optimally controlled or relatively low by 
American Diabetes Association standards may 
be at highest risk for further lowering of BP by 
ozone or high temperature.
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